Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes
Ist Teil von
Basic research in cardiology, 2021-12, Vol.116 (1), p.13-13, Article 13
Ort / Verlag
Berlin/Heidelberg: Springer Berlin Heidelberg
Erscheinungsjahr
2021
Quelle
MEDLINE
Beschreibungen/Notizen
Atrial fibrillation (AF) is associated with electrical remodeling, leading to cellular electrophysiological dysfunction and arrhythmia perpetuation. Emerging evidence suggests a key role for epigenetic mechanisms in the regulation of ion channel expression. Histone deacetylases (HDACs) control gene expression through deacetylation of histone proteins. We hypothesized that class I HDACs in complex with neuron-restrictive silencer factor (NRSF) determine atrial K
+
channel expression. AF was characterized by reduced atrial
HDAC2
mRNA levels and upregulation of
NRSF
in humans and in a pig model, with regional differences between right and left atrium. In vitro studies revealed inverse regulation of
Hdac2
and
Nrsf
in HL-1 atrial myocytes. A direct association of HDAC2 with active regulatory elements of cardiac K
+
channels was revealed by chromatin immunoprecipitation. Specific knock-down of
Hdac2
and
Nrsf
induced alterations of K
+
channel expression.
Hdac2
knock-down resulted in prolongation of action potential duration (APD) in neonatal rat cardiomyocytes, whereas inactivation of
Nrsf
induced APD shortening. Potential AF-related triggers were recapitulated by experimental tachypacing and mechanical stretch, respectively, and exerted differential effects on the expression of class I HDACs and K
+
channels in cardiomyocytes. In conclusion, HDAC2 and NRSF contribute to AF-associated remodeling of APD and K
+
channel expression in cardiomyocytes via direct interaction with regulatory chromatin regions. Specific modulation of these factors may provide a starting point for the development of more individualized treatment options for atrial fibrillation.